Abstract:Since its discovery in 2012, the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) system has supposed a promising panorama for developing novel and highly precise genome editing-based gene therapy (GT) alternatives, leading to overcoming the challenges associated with classical GT. Classical GT aims to deliver transgenes to the cells via their random integration in the genome or episomal persistence into the nucleus through lentivirus (LV) or adeno-associated virus (AAV), respectively. Although high transgene expression efficiency is achieved by using either LV or AAV, their nature can result in severe side effects in humans. For instance, an LV (NCT03852498)- and AAV9 (NCT05514249)-based GT clinical trials for treating X-linked adrenoleukodystrophy and Duchenne Muscular Dystrophy showed the development of myelodysplastic syndrome and patient's death, respectively. In contrast with classical GT, the CRISPR/Cas9-based genome editing requires the homologous direct repair (HDR) machinery of the cells for inserting the transgene in specific regions of the genome. This sophisticated and well-regulated process is limited in the cell cycle of mammalian cells, and in turn, the nonhomologous end-joining (NHEJ) predominates. Consequently, seeking approaches to increase HDR efficiency over NHEJ is crucial. This manuscript comprehensively reviews the current alternatives for improving the HDR for CRISPR/Cas9-based GTs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the knock - in efficiency in the CRISPR/Cas9 gene - editing technology. Specifically, the paper focuses on how to enhance the homology - directed repair (HDR) pathway through different strategies, so as to insert the desired DNA sequence at a specific genomic location. This has significant advantages compared to traditional gene therapy (GT) methods, because traditional methods usually rely on random integration or non - integration, which may lead to serious side effects. ### Background of the Paper Since the discovery of the CRISPR/Cas9 system in 2012, it has shown great potential in the field of gene editing, especially in developing new, high - precision alternatives to gene therapy (GT). Traditional gene therapy randomly integrates exogenous genes into the genome through viral vectors (such as lentivirus LV or adeno - associated virus AAV) or exists in the nucleus in a non - integrated form. Although these methods can achieve efficient gene expression, they may cause serious side effects, such as myelodysplastic syndrome or patient death. ### Core of the Problem CRISPR/Cas9 gene editing relies on the cell's homology - directed repair (HDR) mechanism to precisely insert exogenous genes into specific positions in the genome. However, the HDR mechanism is restricted by the cell cycle in mammalian cells, while the non - homologous end - joining (NHEJ) mechanism is dominant. Therefore, finding ways to improve HDR efficiency is an important direction in current research. ### Main Challenges 1. **Low HDR Efficiency**: The HDR mechanism has low efficiency in mammalian cells, while the NHEJ mechanism is more active. 2. **Mono - allelic Modification**: Gene editing mainly leads to mono - allelic modification in human cells, that is, only one gene copy is edited, while the other copy remains unchanged or is undesirably modified. 3. **Influence of Intrinsic Cell Parameters**: Factors such as cell cycle, chromatin conformation, and cell type can all significantly affect gene - editing efficiency. 4. **Design Parameters**: Design parameters of the CRISPR/Cas9 system, such as single - guide RNA (sgRNA), donor template, delivery platform, and Cas9 variants, are also crucial for gene - editing efficiency. ### Solutions The paper reviews in detail various current strategies for improving CRISPR/Cas9 - mediated HDR efficiency, including: 1. **Blocking the NHEJ Pathway**: Promote the HDR pathway by inhibiting key factors in the NHEJ pathway, such as Ku70/80, DNA - PKcs, etc. 2. **Enhancing the HDR Pathway**: Improve HDR efficiency by over - expressing key factors in the HDR pathway, such as BRCA1, RAD51, etc. 3. **Optimizing CRISPR/Cas9 Design**: Select appropriate sgRNA, donor template and delivery platform, and use high - fidelity Cas9 variants. 4. **Cell - Cycle Regulation**: Regulate the cell cycle to make the cells in the S/G2 phase, thereby improving HDR efficiency. ### Conclusion Improving CRISPR/Cas9 - mediated HDR efficiency is of great significance for achieving precise gene editing and developing new gene - therapy methods. By comprehensively reviewing existing strategies, the paper provides a valuable reference for future research.

Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair

Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells

Topoisomerase Inhibitors and PIM1 Kinase Inhibitors Improve Gene Editing Efficiency Mediated by CRISPR-Cas9 and Homology-Directed Repair

Strategies for generation of mice via CRISPR/HDR-mediated knock-in

Computationally guided high-throughput engineering of an anti-CRISPR protein for precise genome editing in human cells

Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing

CRISPR/Cas9 Technology: Challenges and drawbacks

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

CRISPER/CAS: A potential tool for genomes editing

Delivering CRISPR: a review of the challenges and approaches

Nano-vectors for CRISPR/Cas9-mediated genome editing

Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing

Abstract 5607: A highly efficient donor system for CRISPR knock-in editing

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR Technology

A CRISPR/Cas9-Gal4BD donor adapting system for enhancing homology-directed repair.